locator iconlocator icon
All Labs
 
add to cart

Anti Mullerian Hormone

18001260
30% Coupon
4.1
NABL, CAP, ISO
ADD TO CART
Overview
Interpretations
FAQ's
Anti Mullerian Hormone

Overview of Anti Mullerian Hormone

What is Anti Mullerian Hormone?

Anti Mullerian Hormone (AMH), also known as the Müllerian-inhibiting hormone (MIH) is a naturally produced hormone by the sex organs (testes in males and ovaries in females) that determine development and functioning of the reproductive organs. AMH levels may also indicate certain health conditions. The AMH Test measures the levels of Anti Mullerian Hormone or AMH in blood.

Sample Type

The sample type collected for Anti Mullerian Hormone is: Blood

Preparation for Anti Mullerian Hormone

  • No special preparation required

Why Get Tested for Anti Mullerian Hormone?

The AMH Test is performed:

·        To evaluate the functioning of the ovaries and female fertility (ovarian reserve of eggs) in adult women

·      To determine the external sex organs of an infant in case of ambiguous genitalia (a condition where the external sex organs are not clearly distinguishable into male or female)

·         To help in the diagnosis of Polycystic Ovarian Syndrome (PCOS)

·         To evaluate testicular functioning in infant males

·         To monitor treatment efficacy for some ovarian cancers

·      To determine the efficacy of assisted reproductive procedures like IVF (In Vitro Fertilisation)



Understand more about Anti Mullerian Hormone

Anti Mullerian Hormone or AMH is produced primarily by the testicles in males and the ovaries in females. AMH levels in blood determine and regulate a number of activities of the human reproductive system.

In the first few weeks of foetal development during pregnancy, the foetus has both the primordial male and female reproductive systems and can develop either as male or female. In genetic males, high amounts of AMH are secreted by the testicles, suppressing the formation and development of the female reproductive organs from Mullerian ducts (primordial female reproductive system), and encouraging the development of other male sex organs, which results in the development of a male child. Low or no AMH secreted in the genetically female foetus causes the formation and development of female reproductive organs from the Mullerian duct and a female child is developed. Abnormalities in AMH levels in the foetus may cause the formation of ambiguous genitalia.

After birth, AMH levels remain high in males till puberty, after which they fall slowly and tapers off. AMH levels in females remain low after birth till puberty. During puberty, AMH is secreted by the ovaries resulting in sharp increase in its levels which slowly fall throughout the female reproductive period and become very low to undetectable after menopause. AMH maintains a balance of the two important female reproductive hormones: Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH), which regulate maturation and release of eggs from the ovaries along with other hormones. Hence, AMH levels during the female reproductive period serve as an indication of the ovarian reserve (number of remaining eggs that can mature fully and be released for reproduction), and hence fertility. It is also an indicator of the onset of menopause, especially in older women.

AMH can also be produced by ovarian cysts formed during PCOS, as well as by some types of ovarian tumors.


What Results of Anti Mullerian Hormone mean?

Interpretations

Males:

Age

Blood AMH Level

Below 24 months

14 to 466 ng/ml

24 months to 12 years

7.4 to 243 ng/ml

Above 12 years

0.7 to 19 ng/ml


Females:

Age

Blood AMH Level

Below 24 months

Below 4.7 ng/ml

24 months to 12 years

Below 8.8 ng/ml

13 to 45 years

0.9 to 9.5 ng/ml

Above 45 years

Below 1.0 ng/ml

 

Results in the normal range indicate high fertility and ovarian reserve and a high chance of IVF success.

Results in the low normal range indicate low fertility and ovarian reserve and a reduced but fair chance of IVF success

Results in the very low range indicate a very low ovarian reserve and low chances of reproductive success with IVF.

High AMH levels are usually seen in PCOS and some AMH producing ovarian tumors.


Patient Concerns about Anti Mullerian Hormone

Frequently Asked Questions about Anti Mullerian Hormone

Q. How is this test performed?
This test is performed on a blood sample. A syringe with a fine needle attached is used to withdraw blood sample from a blood vessel in your arm generally from the inner side of the elbow area. The doctor, nurse or the phlebotomist will tie an elastic band around your arm which will help the blood vessels to swell with blood and hence makes it easier to withdraw blood. You may be asked to tightly clench your fist. Once the veins are clearly visible, the area is cleaned with an antiseptic solution and then the needle is inserted into the blood vessel to collect the sample. You may feel a tiny pinprick during the procedure. Blood sample once collected is then sent to the laboratory.
Q. Is there any risk associated with this test?
There is no risk associated with the test. However, as this test involves a needle prick to withdraw the blood sample, rarely, a patient may experience increased bleeding, hematoma (blood collection under the skin) formation, bruising or infection at the site of needle prick.
+ more

Provided By

NABL

CAP

ISO

With a decade of experience under its belt, Oncquest is known for its excellence in Clinical Diagnostics. From its first avatar as an R&D focused entity, Oncquest has evolved into a reference laboratory in the field of Oncology, and more recently into a multi-platform Pathology Services provider with a core focus in Molecular Pathology and Surgical Pathology Services. Its logistic capabilities and geographical spread makes Oncquest an ideal associate for clinical activities in India. Oncquest’s accredited quality systems ensure customer satisfaction through any of its customer-centric service offerings. Oncquest’s recent advances in the areas of Companion Diagnostics and Pharmacogenomics have also allowed for and encouraged greater penetration of Personalized Medicine into the Indian healthcare market, making it the future epicentre of the many technological advancements in healthcare, to come. Its close association with many Hospitals across India stands testament to the faith that Oncquest has instilled in the doctors and patients which avail of its services. Oncquest is fast becoming a cornerstone for a blooming healthcare industry. With over a decade of experience in the field of molecular diagnostics and pathology services, Oncquest Laboratories has earned its reputation of clinical excellence in the Indian market. Our advanced technologies and global quality systems have ensured that we stay ahead of the curve, and this has resulted in our association with some of the most advanced clinicians, hospitals and research organizations in the country. As India gets set for a clinical revolution, ushering in a trend of new healthcare services and products, Oncquest has defined its place as a partner of choice for those who bring value to our proud subcontinent. Our national reach and sizeable knowledge base allows us to be at the forefront of scientific advances, and an ideal partner for clinical activities. We strive to be connected with the best in the industry and we welcome partnership in ideas and technologies. For example, Oncquest’s early adoption and utilization of genetic sequencing technologies has resulted in many “first to market” assays, which have subsequently been adopted in several treatment and monitoring protocols. Innovation is an essential part of our DNA. We welcome challenges, and look forward to associating with you and your organizations to develop pioneering solutions and to tackle some of the most pressing issues faced in our world.

Available at Other Labs

VIEW ALL